A rabbit-derived Lactobacillus johnsonii strain and its application
By using rabbit-derived Lactobacillus johnsonii B2-3, the problem of decreased immunity and production performance caused by oxidative stress in rabbit farming was solved, the growth and slaughter performance of rabbits were improved, and the antioxidant capacity was enhanced.
Patent Information
- Application Number
- CN202310651965.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-01
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-06-01
AI Technical Summary
In rabbit farming, oxidative stress leads to decreased immunity, reduced production performance, and lower meat quality, and existing technologies lack effective rabbit-derived probiotic solutions.
Rabbit-derived Lactobacillus johnsonii B2-3 is used. It has the characteristics of acid resistance, bile salt resistance, heat resistance, strong antibacterial ability, high hydrophobicity and self-aggregation rate, and strong antioxidant ability. It is used to prepare antioxidants, prevent and treat animal infections, and alleviate oxidative stress.
It significantly improves the growth and slaughter performance of rabbits, alleviates the negative impact of oxidative stress on production performance, enhances antioxidant function, and improves immunity.
Smart Images

Figure BDA0004265490020000061 
Figure BDA0004265490020000062 
Figure BDA0004265490020000071
Abstract
Description
Technical Field
[0001] This invention belongs to the field of microbial technology, specifically relating to a rabbit-derived Lactobacillus johnsonii strain and its applications. Background Technology
[0002] my country is the world's largest rabbit-raising country, with its total production and export volume of rabbit meat, fur, and wool ranking first globally for many consecutive years. Compared to other livestock and poultry meats, rabbit meat boasts nutritional characteristics of being "high in protein, high in lysine, high in phospholipids, low in fat, low in cholesterol, and low in calories." These nutritional characteristics meet the demands of modern consumers for healthy diets. Consequently, rabbit meat products have experienced rapid development over the past 20 years and have gained increasing attention worldwide. Furthermore, with economic development, people's focus in raising animals has gradually shifted from executive functions to fulfilling emotional needs. Pets are widely accepted as companion animals and even new family members. Currently, the domestic pet market is entering a period of rapid development, and the pet economy is gradually becoming a sunrise industry. Pet rabbits, as a new type of companion animal, have become a popular choice after dogs and cats, occupying a certain market share.
[0003] Rabbits are highly sensitive to external stimuli. In modern large-scale farming, with increasing intensification, oxidative stress is prevalent in animals due to improper management and uncontrollable factors. Chronic or long-term stress, such as environmental stress, transportation stress, physical stress, and chemical stress, can put animals in a state of oxidative damage, easily leading to various systemic and metabolic diseases. This results in decreased immunity, reproductive performance, growth performance, and meat quality, severely reducing economic benefits and limiting the development of the rabbit farming industry. Since rabbitry environments differ significantly from natural environments, special attention should be paid to the development of technologies and products that alleviate stress and reduce inflammatory responses during feed product development to ensure the health and production performance of rabbits. Dexamethasone (Dex) is a long-acting glucocorticoid. Studies suggest that elevated plasma glucocorticoid levels are an important marker of stress response. Therefore, certain physicochemical indicators that change in the animal's body during stress can be used as stress factors to stimulate stress in animals; for example, injecting Dex can act as a stressor. Oxidative stress not only causes significant losses to the livestock industry, but also leads to a decline in the quality of livestock and poultry products due to the accumulation of oxidation products, thereby affecting food hygiene and endangering human health and environmental safety. How to mitigate oxidative stress in animals has become a research hotspot in the livestock industry.
[0004] Probiotics are widely recognized for their numerous health benefits, playing a positive role in strengthening the intestinal barrier, enhancing immunity, improving productivity, and boosting antioxidant capacity. In vitro and in vivo studies have demonstrated that probiotics possess antioxidant potential, exerting their antioxidant function through multiple pathways and improving the antioxidant capacity of animals. Therefore, consuming probiotics alone or supplementing with probiotic-rich foods can reduce oxidative damage. Ideally, probiotic strains should be selected from animals of the same lineage and be able to tolerate the harsh environmental factors of the host's gastrointestinal tract. *Lactobacillus johnsonii* belongs to the phylum Firmicutes, class Bacilli, order Lactobacillales, family Lactobacillaceae, and genus *Lactobacillus*. The European Food Safety Authority (EFSA) issued three health statements for *Lactobacillus johnsonii* in 2009 and 2011, stating that it reduces pathogenic bacteria in the gut, enhances the natural defense and immune system, and maintains healthy skin. The EU also granted *Lactobacillus johnsonii* a qualified presumption of safety (QPS) designation for its use in animal feed and food. In 2010, the General Office of the Ministry of Health of my country included *Lactobacillus johnsonii* in the "List of Microbial Strains that Can Be Used in Food," approving its use as a food additive with probiotic functions.
[0005] Dexamethasone, a glucocorticoid, is a key regulator of oxidative stress in animals and can fundamentally mimic the state of oxidative stress. Therefore, glucocorticoids are frequently used to establish animal stress models in oxidative stress research. Currently, most research on animal models focuses on chickens and mice; the effects of probiotics on dexamethasone-induced stress in rabbits have not been reported. Ideally, probiotic strains should be selected from animals of the same species and be able to tolerate the harsh environmental factors of the gastrointestinal tract of the same species, thereby better exerting their probiotic properties and achieving maximum therapeutic and health-promoting effects. However, there are few reports on rabbit-derived *Lactobacillus johnsonii*, and even fewer corresponding products on the market. Summary of the Invention
[0006] The purpose of this invention is to provide a rabbit-derived Lactobacillus johnsonii strain that is acid-resistant, bile-resistant, heat-resistant, has strong antibacterial ability, is hydrophobic and has high self-agglutination rate, and has strong antioxidant capacity. This strain can significantly improve the growth and slaughter performance of rabbits and alleviate the impact of oxidative stress on the production performance and antioxidant function of rabbits.
[0007] To achieve the above objectives, the present invention adopts the following technical solution:
[0008] Rabbit-derived Lactobacillus johnsonii B2-3, preservation number CCTCC NO: M2023606.
[0009] Application of rabbit-derived Lactobacillus johnsonii B2-3 in the preparation of antioxidants: In vitro antioxidant experiments of Lactobacillus johnsonii B2-3 showed that the DPPH free radical scavenging rate was 24.42% and the anti-lipid peroxidation rate was 38.6%, indicating that it has strong in vitro antioxidant capacity, suggesting that Lactobacillus johnsonii B2-3 has the potential to be a probiotic to enhance the host's antioxidant capacity.
[0010] Application of rabbit-derived Lactobacillus johnsonii B2-3 in the preparation of products for the prevention and treatment of animal infections with Escherichia coli, Salmonella enteritidis, Listeria monocytogenes, or Clostridium perfringens: In vitro antibacterial experiments of Lactobacillus johnsonii B2-3 showed that it had a strong inhibitory effect on Escherichia coli, Salmonella enteritidis, Listeria monocytogenes, and Clostridium perfringens.
[0011] Application of rabbit-derived Lactobacillus johnsonii B2-3 in the preparation of drugs to alleviate or treat oxidative stress in animals: In a specific embodiment of the present invention, oxidative stress was induced in rabbits by subcutaneous injection of dexamethasone sodium phosphate. The experiment showed that the addition of rabbit-derived Lactobacillus johnsonii B2-3 could significantly improve the growth performance (including body weight and feed conversion ratio) and slaughter performance (including live weight, eviscerated weight, semi-eviscerated weight, thymus and thymus index, etc.) of rabbits, and alleviate the negative effects of dexamethasone-induced serum biochemical and antioxidant enzyme disorders, liver pathological damage, and intestinal mucosal morphological damage.
[0012] Application of rabbit-derived Lactobacillus johnsonii B2-3 in improving animal production performance: In a specific embodiment of the present invention, compared with the control, the addition of rabbit-derived Lactobacillus johnsonii B2-3 can improve the production performance of rabbits (including average daily weight gain and feed conversion ratio) and improve the slaughter performance of rabbits (including live weight, eviscerated weight, and semi-eviscerated weight).
[0013] An animal microbial preparation containing rabbit-derived Lactobacillus johnsonii B2-3.
[0014] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0015] The *Lactobacillus johnsonii* B2-3 (CCTCC NO: M 2023606) provided by this invention is the first strain isolated and screened from healthy rabbits. In vitro tests, including acid and bile salt tolerance tests, antioxidant tests, hydrophobicity and self-agglutination tests, antibacterial tests, and drug resistance tests, have confirmed that this strain has good gastrointestinal colonization ability and safety. It also possesses multiple probiotic functions, such as inhibiting pathogens and providing antioxidant effects. This can alleviate the negative impacts of oxidative stress on production performance, serum biochemical and antioxidant enzyme imbalances, liver pathological damage, and intestinal mucosal morphology damage. *Lactobacillus johnsonii* B2-3 has the potential to be a probiotic and has a very broad application prospect. Attached Figure Description
[0016] Figure 1 This is the growth curve of Lactobacillus johnsonii B2-3 in Example 2 of the present invention.
[0017] Figure 2 The results of the heat resistance test of Lactobacillus johnsonii B2-3 in Example 4 of this invention are shown.
[0018] Figure 3 This is the autoagglutination curve of Lactobacillus johnsonii B2-3 in Example 6 of the present invention.
[0019] Figure 4 This is the hemolysis test result of Lactobacillus johnsonii B2-3 in Example 9 of the present invention. The left image shows Staphylococcus aureus (positive control), and the right image shows Lactobacillus johnsonii B2-3.
[0020] Figure 5 This describes the effect of Lactobacillus johnsonii B2-3 on antioxidant indices in rabbits under oxidative stress, as shown in Example 10 of this invention. Note: * indicates P < 0.05, significant difference; ** indicates P < 0.01, extremely significant difference; *** indicates P < 0.001, extremely significant difference.
[0021] Figure 6 This invention illustrates the effect of *Lactobacillus johnsonii* B2-3 on liver pathological changes in rabbits under oxidative stress in Example 10. Note: C: control group; B: *Lactobacillus johnsonii* B2-3 group; D: Dex group; BD: B2-3 + Dex group. Detailed Implementation
[0022] The present invention will now be described clearly and completely. Obviously, the described embodiments are only a part of the embodiments of the present invention, and not all of them. The following examples are for illustrative purposes only and should not be considered as limiting the scope of the invention. Where specific conditions are not specified in the examples, conventional conditions or conditions recommended by the manufacturer shall apply.
[0023] Example 1: Isolation and Identification of Rabbit-Derived Lactobacillus johnsonii
[0024] 1.1 Collecting fecal samples
[0025] On July 25, 2021, fresh feces from healthy rabbits were randomly sampled and stored at -20°C at the breeding farm of Wuhan Bosifu Biotechnology Co., Ltd. The farm had approximately 6,000 experimental rabbits.
[0026] 1.2 Test strains
[0027] Escherichia coli (C83902), Salmonella enteritidis (NCTC13349), Staphylococcus aureus (BNCC186335), Listeria monocytogenes (clinical isolate), and Clostridium perfringens (clinical isolate) are all preserved in this laboratory.
[0028] 1.3 Test Methods
[0029] 1.3.1 Isolation and Screening of Lactic Acid Bacteria
[0030] Thaw rabbit fecal samples stored at -20℃, weigh approximately 1g of fecal sample into 10mL of PBS solution and vortex to mix. After mixing, incubate at 37℃ on a shaker at 180 rpm for 20 min. In a clean bench, serially dilute the sample with sterile PBS solution, and inoculate 100μL of the supernatant from the appropriate dilution onto modified MRS agar medium. Spread the supernatant evenly with a spreader to isolate and culture the bacterial strains. Incubate upside down in a 37℃ incubator for 48 h. Aseptically pick smooth, white or milky white, round colonies with a raised center using an inoculation loop and streak them onto MRS agar plates. Purify and inoculate for 3 generations until the colonies on the plates are similar in morphology, size, and color. Then, pick colonies from the MRS plates for Gram staining and examine them under an optical microscope, recording the staining results (positive bacteria appear purple, negative bacteria appear red). Staining Method: Prepare a clean, sterile glass slide. Place an appropriate amount of distilled water on the slide and observe the agar colonies. Use an inoculation loop to pick up colonies, mix them thoroughly, and spread them over an area of approximately 5 mm. Fix with an alcohol lamp flame. After fixation, begin staining. First step: Add crystal violet solution to the fixed slide for 1 minute, then rinse with running water and blot dry with absorbent paper. Second step: Mordant: Apply iodine solution evenly to the slide for 1 minute, then rinse with running water and blot dry with absorbent paper. Third step: Rinse the slide with 95% alcohol. Fourth step: Counterstain: Add safranin for 2 minutes, then rinse with water. Finally, allow the slide to air dry. Place the slide under a microscope and observe the colony morphology under an oil immersion lens, discarding any Gram-negative strains. Finally, purified colonies were picked and inoculated into MRS nutrient liquid medium. After the strains were numbered and recorded, they were amplified and cultured at 180 r / min in a constant temperature shaker at 37℃ for 18-24 h.
[0031] Twenty-three pure amplified cultures were isolated from rabbit feces. The isolated strains were first isolated in an acidic environment of pH 3.0 and 0.8 mmol / L H2O2 (OD2). 600 Initial screening was typically performed using a concentration greater than 1.0. The results showed that one strain, designated B2-3, was growing well.
[0032] 1.3.2 Molecular Identification
[0033] Bacterial DNA was extracted according to the bacterial DNA extraction kit instructions. PCR amplification was performed using universal primers for the bacterial 16S rRNA gene, and sequencing was also performed using universal primers: 27F: 5'-AGAGTTTGATCCTGGCTCAG-3', 1492R: 5'-TACGGTTACCTTGTTACGA CTT-3'. The PCR amplification system (25 μL) consisted of 13 μL mix, 8 μL ddH2O, 1 μL each of forward and reverse primers, and 2 μL DNA. Reaction conditions: 95℃ pre-denaturation for 5 min; 94℃ denaturation for 1 min, 54℃ annealing for 45 sec, 72℃ extension for 1 min, 40 cycles; 72℃ extension for 10 min. The amplified products were subjected to 1.5% agarose gel electrophoresis, and the band clarity was observed and preserved using a gel imaging system. Finally, the PCR product was sent to Wuhan Qingke Biotechnology Co., Ltd. for sequencing. BLAST alignment analysis of the sequencing results (SEQ ID NO.1) with the NCBI database revealed that B2-3 was *Lactobacillus johnsonii*. This strain was deposited on April 24, 2023, at the China Center for Type Culture Collection (CCTCC), Wuhan University, Wuhan, China, accession number CCTCC NO: M 2023606.
[0034] Example 2: Growth characteristics of Lactobacillus johnsonii B2-3
[0035] Lactobacillus johnsonii B2-3 was inoculated into MRS broth and amplified in a shaker at 37°C and 180 rpm for 24 h. Then, it was re-inoculated into fresh, sterile MRS broth at a 2% inoculum volume, vortexed, and 200 μL was added to a honeycomb plate. Each sample was replicated in triplicate. OD values were recorded using an automated growth curve analyzer. 600 (Set the optical density value at a wavelength of 600nm to be recorded every 2 hours).
[0036] Depend on Figure 1 It can be seen that Lactobacillus johnsonii B2-3 is in the lag phase during the first 2 hours, in the logarithmic phase from 2 to 8 hours with the fastest proliferation rate; the growth rate slows down from 10 to 12 hours; strain B2-3 has a relatively high biomass during the 10-20 hour period, and basically enters the plateau phase after 12 hours.
[0037] Example 3: Survival rate determination of Lactobacillus johnsonii B2-3 in acid and bile salts
[0038] 3.1 Acid resistance test
[0039] Lactobacillus johnsonii B2-3 was inoculated into MRS liquid medium and cultured at 37°C for 24 h. After reaching the stable growth phase, the bacterial culture was inoculated at a 5% inoculum into MRS liquid medium at pH 3.0. Samples were collected at 0 h and 3 h of the experiment, serially diluted with sterile PBS, and 100 μL of the appropriately diluted culture was spread onto MRS solid medium. After static incubation at 37°C for 24 h, the bacterial counts were performed. The experiment was repeated three times. Calculations were performed using the following formula:
[0040]
[0041] In the formula, A3 = the number of viable Lactobacillus johnsonii B2-3 after acid treatment for 3 hours; A0 = the number of viable Lactobacillus johnsonii B2-3 in the initial solution.
[0042] 3.2 Bile salt tolerance test
[0043] Lactobacillus johnsonii B2-3 was inoculated into MRS liquid medium and cultured at 37°C for 12-16 hours. The culture, having reached the stable growth phase, was then inoculated at a 5% inoculum into MRS liquid medium containing 0.3% porcine bile salts (w / v%). Samples were collected at 0 hours and 3 hours after the experiment. The samples were serially diluted with sterile PBS, and 100 μL of the appropriately diluted culture was spread onto MRS solid medium. After static incubation at 37°C for 24 hours, the bacterial counts were performed. The experiment was repeated three times.
[0044]
[0045] In the formula, B3 = the number of viable Lactobacillus johnsonii B2-3 after 3 hours of bile salt treatment; B0 = the number of viable Lactobacillus johnsonii B2-3 in the initial solution.
[0046] The survival rate of Lactobacillus johnsonii B2-3 in MRS broth at pH 3.0 was 57.51%, with a viable count of 1.93 × 10⁻⁶. 7 CFU / mL; the survival rate of Lactobacillus johnsonii B2-3 in MRS broth with a concentration of 0.3% bile salts was 72.8%, and the viable count was 4.55 × 10⁻⁶. 6 CFU / mL. These results indicate that *Lactobacillus johnsonii* B2-3 has strong tolerance to acid and bile salts.
[0047] Example 4: Heat resistance test of Lactobacillus johnsonii B2-3
[0048] High temperatures can cause protein denaturation, membrane structure disruption, and damage to nucleic acid molecules. Industrial production of lactic acid bacteria often involves high-temperature processes, such as spray drying and pasteurization. Furthermore, heat resistance is positively correlated with the long-term preservation of lactic acid bacteria. Therefore, improving the heat resistance of lactic acid bacteria is crucial for enhancing their commercial value.
[0049] Lactobacillus johnsonii B2-3 was inoculated into MRS broth and cultured at 37°C with a shaker at 200 rpm for 24 h. Then, it was re-inoculated into fresh, sterile MRS broth at a 2% inoculum size and treated in water baths at 45°C, 55°C, and 65°C for 10 min, 20 min, and 30 min, respectively. No temperature treatment was used as a blank control. Three replicates were performed. The cultures were vortexed, and the optical density of the bacterial culture at 600 nm was measured using a UV-Vis spectrophotometer. The data were recorded. Each culture was then incubated at 37°C with a shaker for 8 h, and the OD600 was measured again. 00 .
[0050] The results of the temperature tolerance test for Lactobacillus johnsonii B2-3 are as follows: Figure 2 As shown, at 45℃, the tolerance and growth characteristics of B2-3 are not affected by culture time, OD 600 The levels remained largely the same; at 55℃, the strains' tolerance and growth capacity decreased with prolonged culture time, but they still maintained a certain level of proliferation capacity overall; B2-3's survival rate decreased significantly at 65℃, and its activity was significantly affected.
[0051] Example 5: Antioxidant capacity of Lactobacillus johnsonii B2-3
[0052] Lactobacillus johnsonii B2-3 was inoculated into MRS liquid medium at a 2% inoculum and cultured at 37°C for 12 h. The cells were then collected by centrifugation at 4000 rpm for 15 min at 4°C. The cells were resuspended in PBS buffer and centrifuged at 4000 rpm for 15 min. The culture medium was washed off, and this process was repeated three times. The cells were then collected, resuspended in PBS buffer, and the OD value was adjusted. 600 =1.00, and a suspension of Lactobacillus johnsonii B2-3 was obtained.
[0053] 5.1 The scavenging ability of Lactobacillus johnsonii B2-3 against DPPH free radicals
[0054] Take 2 mL of the sample to be tested (Lactobacillus johnsonii B2-3 suspension), add 1 mL of 0.2 mmol / L 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH) anhydrous ethanol solution, mix well, let stand at room temperature in the dark for 30 min, react in the dark for 30 min, then centrifuge at 9000 r / min for 10 min, and measure the absorbance of the supernatant at 517 nm. The formula for calculating the DPPH free radical scavenging rate is:
[0055]
[0056] In the formula, A0 is the absorbance value of an equal volume of anhydrous ethanol replacing the sample; A1 is the absorbance value of the sample to be tested; and A2 is the absorbance value of an equal volume of anhydrous ethanol replacing the DPPH ethanol solution.
[0057] 5.2 Reducing capacity of Lactobacillus johnsonii B2-3
[0058] Take 0.5 mL of the test sample (Lactobacillus johnsonii B2-3 suspension), add 0.5 mL of PBS buffer solution (0.2 mol / L, pH = 6.6) and 0.5 mL of potassium ferricyanide (1% by mass), mix well, and place in a 50℃ constant temperature water bath for 20 min, then cool rapidly in ice water. Add 0.5 mL of trichloroacetic acid (10% by mass), centrifuge at 4000 rpm for 5 min, take 1 mL of the supernatant, add 1 mL of distilled water and 1 mL of ferric chloride (0.1% by mass), mix well, react for 10 min, and measure the absorbance at 700 nm wavelength; this is B1. Using PBS instead of the test sample results in B0. The reducing power calculation formula is:
[0059]
[0060] In the formula, B0 = absorbance value of an equal volume of PBS replacing the sample to be tested; B1 = absorbance value of the sample to be tested. 5.3 Anti-lipid peroxidation capacity of Lactobacillus johnsonii B2-3
[0061] Add 1 mL of linoleic acid emulsion and 1 mL of FeSO4 (1% by mass) to 0.5 mL of PBS solution (pH = 7.4), then add 0.5 mL of the test sample (Lactobacillus johnsonii B2-3 suspension). Incubate at 37°C for 1.5 h, remove and mix thoroughly. Add 0.2 mL of TCA (4% by mass) and 2 mL of TBA (0.8% by mass), incubate at 100°C for 30 min, cool in ice water, centrifuge at 4000 r / min for 15 min, collect the supernatant, and measure its absorbance at 532 nm, recorded as C1. The control group is prepared by replacing the test sample with 0.5 mL of PBS, with all other parameters remaining unchanged; the absorbance is recorded as C0. The formula for calculating the anti-lipid peroxidation rate is:
[0062]
[0063] In the formula, C0 = the absorbance value of an equal volume of PBS replacing the sample to be tested; C1 = the absorbance value of the sample to be tested.
[0064] Based on the measurement results, the DPPH free radical scavenging rate of *Lactobacillus johnsonii* B2-3 was calculated to be 24.42%, the reducing power was 10.41%, and the anti-lipid peroxidation rate was 38.6%, indicating strong in vitro antioxidant capacity. Example 6: Hydrophobicity and self-agglutination test of *Lactobacillus johnsonii* B2-3.
[0065] 6.1 Test for hydrophobicity of Lactobacillus johnsonii B2-3
[0066] The *Lactobacillus johnsonii* B2-3 fermentation broth was centrifuged at 8000 rpm for 15 min. The bacterial precipitate was washed twice with PBS, and then PBS was added again and mixed thoroughly to adjust the absorbance (OD(600nm)) to 0.5 ± 0.05. 4 ml of *Lactobacillus johnsonii* B2-3 culture medium was mixed with an equal volume of xylene, and the absorbance of the aqueous phase at 600 nm was measured. After shaking in a 37℃ water bath for 5 min, the mixture was placed in a 37℃ incubator, and the absorbance of the aqueous phase was measured after 2 h. The hydrophobicity was calculated using the following formula:
[0067]
[0068] In the formula, A0 = absorbance of Lactobacillus johnsonii B2-3 after 0 h; A2 = absorbance of Lactobacillus johnsonii B2-3 after 2 h of treatment.
[0069] 6.2 Test for the self-agglutination ability of Lactobacillus johnsonii B2-3
[0070] The fermentation broth of *Lactobacillus johnsonii* B2-3 was centrifuged at 8000 rpm for 15 min. The bacterial precipitate was washed twice with PBS, then PBS was added and mixed thoroughly. The OD (600 nm) was adjusted to 0.5 ± 0.05, and the mixture was incubated at 37℃ for 24 h. After 0, 2, 4, 6, 12, and 24 h, the centrifuge tubes containing the bacterial culture were slowly removed from the incubator, and 1 mL of the supernatant was aspirated using a micropipette. The absorbance at 600 nm was measured. The autoagglutination rate was calculated using the following formula:
[0071]
[0072] In the formula, B0 = absorbance of Lactobacillus johnsonii B2-30 h; B t = Absorbance values of Lactobacillus johnsonii B2-3 at various treatment times.
[0073] Studies have found that highly hydrophobic bacterial strains have a strong binding ability to mucosal cells or a strong affinity for epithelial cells / mucus layers. The higher the hydrophobicity of the strain, the better its adhesion ability. The specific criteria between hydrophobicity and hydrophobicity rate are: hydrophobic interaction force (%) > 50% indicates highly hydrophobic; hydrophobic interaction force (%) < 20% indicates non-hydrophobic; and anything in between indicates moderate hydrophobicity. Lactobacillus johnsonii B2-3 has a hydrophobic interaction force of 76.23%, exhibiting high hydrophobicity.
[0074] The autocoagulation rate reflects the ability of lactic acid bacteria to adhere to intestinal epithelial cells; the higher the autocoagulation rate, the stronger the ability of lactic acid bacteria to attach to intestinal epithelial cells. For example... Figure 3 As shown, the autoagglutination rate gradually increased over the 24 hours of culture, reaching its highest value at 24 hours, with Lactobacillus johnsonii B2-3 achieving an autoagglutination rate of 88.2%.
[0075] Example 7: Antibacterial test of Lactobacillus johnsonii B2-3
[0076] Escherichia coli (C83902), Salmonella enteritidis (NCTC13349), Staphylococcus aureus (BNCC186335), and Listeria monocytogenes (clinical isolate) were activated three times on LB agar plates. Single colonies were picked and inoculated into LB broth and cultured at 37°C with a shaker at 200 rpm for 12 h. Clostridium perfringens (clinical isolate) was activated three times on TSC agar plates. Single colonies were picked and inoculated into RCM broth and cultured anaerobically at 37°C with a shaker at 200 rpm for 12 h. The agar diffusion method was used for antibacterial tests. The pathogen indicator bacterial suspension was evenly spread onto LB agar plates and reinforced Clostridium agar plates using sterile cotton swabs. After drying for a few minutes, three sterile Oxford cups were placed at equal intervals on the LB agar plates and reinforced Clostridium agar plates using sterile forceps to make holes. The Oxford cups and the agar in the holes were removed, and the plates were then sealed with hot iron. Lactobacillus johnsonii B2-3 was activated and cultured in MRS broth for 24 hours. After vortexing, 100 μL of the bacterial solution was added to each well (three replicates). The wells were incubated at room temperature for several hours until the bacterial solution was completely absorbed. LB agar plates were then inverted and incubated overnight at 37°C. Clostridium perfringens agar plates were placed in anaerobic culture bags and inverted again for overnight incubation at 37°C. The presence of inhibition zones was observed, and their diameter was measured using calipers and recorded (unit: mm). MRS broth without bacterial inoculation served as a negative control.
[0077] Table 1. Antibacterial activity of Lactobacillus johnsonii B2-3
[0078]
[0079] Lactobacillus johnsonii B2-3 showed strong inhibitory effects on Escherichia coli, Salmonella enteritidis, Listeria monocytogenes, and other bacteria, and also showed strong inhibitory effects on Clostridium perfringens, with an inhibition zone diameter of 31.43±0.63 mm.
[0080] Example 8: Antimicrobial susceptibility testing of Lactobacillus johnsonii B2-3
[0081] The drug susceptibility of isolated *Lactobacillus johnsonii* B2-3 was determined using the Kirby-Bauer test (KB method). Bacterial suspension was inoculated into fresh MRS broth and incubated at 37°C in a shaker for 12-16 hours. 100 μL of the activated bacterial suspension was then evenly spread onto MRS agar plates using a sterile cotton swab. The plates were incubated at room temperature for 5-10 minutes. Four drug susceptibility discs were then placed on each MRS agar plate using sterile forceps and gently pressed down. The plates were inverted and incubated at 37°C for 24 hours. The presence of inhibition zones was observed, and their diameter was measured using calipers and recorded (unit: mm). Drug susceptibility results were determined according to the Clinical and Laboratory Standards Institute (CLSI) standards: sensitive (S), moderately sensitive (I), and resistant (R). The experiment used 21 antibiotics from 11 classes, including β-lactam antibiotics such as penicillin, ampicillin, amoxicillin, cefazolin, cefalexin, and cefaradine; polyene antibiotics such as nystatin; tetracycline antibiotics such as doxycycline and tetracycline; and amide alcohol antibiotics such as chloramphenicol and florfenicol. (enicol); aminoglycosides: gentamicin, streptomycin, kanamycin; macrolides: erythromycin; lincosamides: clindamycin; quinolones: ciprofloxacin, norfloxacin; nitroimidazoles: metronidazole; rifamycins: rifampicin; and glycopeptides: vancomycin.
[0082] The results are shown in Table 2. Strain B2-3 exhibited extremely high sensitivity to β-lactam antibiotics such as ampicillin and cefazolin; resistance to tetracycline antibiotics; and high sensitivity to amyloidol antibiotics such as chloramphenicol and florfenicol. Strain B2-3 was highly sensitive to the aminoglycoside antibiotic streptomycin but resistant to kanamycin. Macrolide antibiotic erythromycin showed high sensitivity; quinolone antibiotics ciprofloxacin and norfloxacin showed moderate sensitivity to resistance; rifamycin antibiotics rifampicin and glycopeptide antibiotic vancomycin showed high sensitivity; and polyene antibiotics nystatin and metronidazole showed resistance. Safety concerns include the risk of antibiotic resistance gene transfer. Lactobacillus johnsonii strains exhibit varying susceptibility to antibiotics, therefore resistance screening must be considered before any probiotic is commercialized.
[0083] Table 2. Results of antibiotic susceptibility testing for Lactobacillus johnsonii B2-3
[0084]
[0085] Example 9: Hemolysis test of Lactobacillus johnsonii B2-3
[0086] Columbia blood agar basal medium was autoclaved and cooled to approximately 50°C. Fresh 5% sterile defibrinated sheep blood was added, gently shaken to mix, and poured into sterile Petri dishes to prepare blood agar plates. Using the three-zone streak method, *Lactobacillus johnsonii* B2-3 was inoculated onto the blood agar plates using an inoculation loop. The plates were inverted and incubated at 37°C for 24 hours. The presence of hemolytic rings was observed to determine the type of hemolysis. A grass-green ring around the colony was assessed as α-hemolysis; a clear area around the colony was considered β-hemolysis, also known as complete hemolysis; no change in colony size was considered γ-hemolysis, i.e., non-hemolysis. *Staphylococcus aureus* was used as a positive control.
[0087] like Figure 4As shown, the positive control *Staphylococcus aureus* colonies exhibited a characteristic clear hemolytic zone, while *Lactobacillus johnsonii* B2-3 colonies grew well on blood agar plates without morphological changes, indicating no hemolysis. Lactic acid bacteria must undergo safety assessments before use; common safety assessments include the absence of virulence, infectivity, and the absence of transferable antibiotic resistance genes. Analysis of the hemolysis and resistance test results revealed that *Lactobacillus johnsonii* B2-3 was non-hemolytic and sensitive to most antibiotics, indicating that this isolated strain is safe and harmless.
[0088] Example 10: Effect of Lactobacillus johnsonii B2-3 on dexamethasone-induced stress in rabbits
[0089] 10.1 Test Methods
[0090] Pre-feeding period and prevention period:
[0091] Twenty male New Zealand White rabbits were selected as the research subjects. They were fed a basal diet and given free access to water. After 5 days of acclimatization, the rabbits were randomly divided into four groups according to their similar weight: control group (Group C), Lactobacillus johnsonii B2-3 group (Group B), dexamethasone group (model group) (Group D), and prevention group (Group BD), with 5 rabbits in each group.
[0092] Each group was fed normal feed and had free access to water daily, with individual nipple drinking bottles provided. The Lactobacillus johnsonii group and the prevention group were given Lactobacillus johnsonii B2-3 bacterial suspension (5 mL / kg / d), with a live bacteria count of 1.0 × 10⁻⁶. 8 CFU / mL, the control group and the model group were given physiological saline (5mL / kg / d) for 23 consecutive days, and their body weight was measured daily to establish a prevention system.
[0093] Dexamethasone stress period:
[0094] After the lactic acid bacteria prevention system was established, the prevention period continued every day at 6:00 PM. At 7:00 PM, each animal in groups D and BD was subcutaneously injected with 2 mg / kg of dexamethasone sodium phosphate injection, while each animal in groups C and B was subcutaneously injected with an equal volume of physiological saline to establish an oxidative stress model. The injections were administered for 7 consecutive days. The total duration of the experiment was 30 days.
[0095] Daily fasting weight and uneaten feed volume were recorded for each experimental rabbit. After the experiment, four rabbits from each group were randomly selected and fasted for 12 hours. Blood was collected from the heart, and the rabbits were euthanized. After removing the fur, the rabbits were weighed. Shoulder fat, perirenal fat, heart, liver, and kidneys were also removed and weighed. The liver was weighed after removing surrounding fat and connective tissue. Two liver pieces were then placed in fixative and cryovials, respectively. Two segments of the jejunum and ileum (approximately 1 cm long) were cut (interrupting the intestine), cleaned with physiological saline, and placed in fixative and cryovials, respectively. The cryovials were flash-frozen in liquid nitrogen and then stored at -80°C.
[0096] 10.2 Feeding and Management
[0097] The experiment was conducted at the Experimental Animal Center of Huazhong Agricultural University from August 17, 2022 to September 21, 2022.
[0098] Experimental Feeding and Management: Before the experiment, the rabbit hutch was thoroughly cleaned, and then the cages were disinfected with a glutaraldehyde-decylmethylammonium bromide solution. Finally, the entire hutch was thoroughly disinfected with ultraviolet light. The selected experimental rabbits were numbered and housed individually, with free access to feed and water. The amount of feed was appropriately controlled; it was advisable to have a slight amount of feed remaining in the feed trough before the next feeding. Uneaten feed was weighed, and the feed intake was calculated. The rabbit hutch was cleaned daily, and the feed troughs were cleaned regularly and the hutch was disinfected with glutaraldehyde. During the experiment, the rabbits' feeding behavior and health status were carefully observed and recorded. No antibiotics or other chemical drugs were used throughout the entire experiment.
[0099] Experimental diet: The basal diet for rabbit experiments was purchased from the Experimental Animal Center of Huazhong Agricultural University. The composition and nutrient levels of the diet are shown in Table 3.
[0100] Table 3. Composition (%) and nutrient levels (%) of the basal diet for rabbit experiments.
[0101]
[0102] 10.3 Determination Method
[0103] 10.3.1 Measurement of Production Performance Indicators
[0104] Average daily weight gain (ADG) = (final weight at the end of the trial - initial weight at the beginning of the trial) / number of days in the trial;
[0105] Average daily feed intake (ADFI) = (feed amount - uneaten feed) / number of days in the trial;
[0106] FCR = Average daily feed intake / Average daily weight gain.
[0107] 10.3.2 Determination of Slaughter Performance Indicators
[0108] At the end of the experiment, four rabbits from each group with an average weight were selected for slaughter. After slaughter, the weights of the eviscerated parts, heart, liver, kidney, spleen, thymus, shoulder fat, and kidney fat were recorded. The eviscerated percentage, semi-eviscerated percentage, and organ index were calculated.
[0109] Fully eviscerated weight (g): After removing the fur, tail, all internal organs, and the parts below the knee joints of the forelimbs and the toe joints of the hindlimbs, the entire body is weighed after standing still for 30 minutes.
[0110] Semi-eviscerated weight (g) = Total eviscerated weight + Heart + Liver + Kidney
[0111] Full eviscerated yield (%) = Full eviscerated weight / Pre-slaughter live weight × 100
[0112] Semi-eviscerated percentage (%) = (Fully eviscerated + Heart + Liver + Kidney) / Pre-slaughter live weight × 100
[0113] Cardiac Index (%) = Spleen weight / Pre-slaughter live weight × 100
[0114] Liver index (%) = Liver weight / Pre-slaughter live weight × 100
[0115] Kidney Index (%) = Kidney weight / Pre-slaughter live weight × 100
[0116] Spleen index (%) = Spleen weight / Pre-slaughter live weight × 100
[0117] Thymus index (%) = thymus weight / pre-slaughter live weight × 100
[0118] Shoulder fat percentage (%) = Shoulder fat weight / Pre-slaughter live weight × 100
[0119] Renal fat percentage (%) = Perirenal fat weight / Pre-slaughter live weight × 100
[0120] 10.3.3 Determination of Blood Biochemical Indicators
[0121] Blood was collected from the heart of experimental rabbits. After collection, the blood was centrifuged at 3000 rpm for 10 min to separate the serum, which was then aliquoted and stored at -80℃. Serum alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bile acids (TBA), total protein (TP), albumin (ALB), glucose (GLU), triglycerides (TG), total cholesterol (TC), urea (UREA), uric acid (UA), and calcium (Ca) were measured using kits provided by Shenzhen Mindray Animal Medical Technology Co., Ltd., following the instructions, and on a Mindray BS240-VET7020 fully automated biochemical analyzer. Serum cortisol levels were measured using kits produced by Beijing Huaying Biotechnology Research Institute.
[0122] 10.3.4 Determination of serum antioxidant markers
[0123] Serum total antioxidant capacity (T-AOC), total superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), and malondialdehyde (MDA) levels were determined using a kit produced by Beijing Huaying Biotechnology Research Institute.
[0124] 10.3.5 Histopathological observation of liver tissue
[0125] The liver tissue was rinsed with 4°C saline. A small piece of liver tissue was taken from the largest lobe of the liver, 5 mm from the edge, and fixed with 100 mL / L formalin. The tissue was then washed, dehydrated with alcohol gradient, cleared, embedded in paraffin, sectioned, mounted, dewaxed and rehydrated, stained with hematoxylin and eosin, and mounted. The changes in the liver tissue were observed under a light microscope.
[0126] 10.3.6 Determination of intestinal morphology and structure in dexamethasone-induced stress rabbits
[0127] The fixed jejunum and ileum tissues were removed, washed, dehydrated, cleared, embedded in paraffin, trimmed, and sectioned. They were then cut into 5μm thick paraffin slides, mounted, and stained with hematoxylin and eosin (HE). After sectioning, images of the jejunum and ileum slides were acquired using an ImageView camera system. Villus height (V) and crypt depth (C) were measured, and the villus-crypt ratio (V / C) was calculated.
[0128] 10.3.7 Data Processing and Analysis
[0129] The raw data were statistically processed using Excel. One-way ANOVA was performed using IBM SPSS 24.0 statistical software. Results are expressed as mean ± standard deviation (Mean ± SD). Multiple comparisons were performed using LSD and Duncan methods. p < 0.05 was considered statistically significant, and p < 0.01 was considered highly statistically significant. GraphPad Prism 9.5.1 software was used for plotting.
[0130] 10.4. Results Analysis
[0131] 10.4.1 Production Performance
[0132] As shown in Table 4, there were no differences in initial body weight among the groups. However, compared with group C, the body weight of rabbits in group B was significantly higher (p<0.05), while the body weight of rabbits in group D was significantly lower; compared with group D, the final body weight of group BD was significantly higher (p<0.05); compared with group C, the ADG of group B was significantly higher; compared with group C, the FCR of group B was significantly lower (p<0.01); compared with group D, the FCR of group BD was significantly lower (p<0.05).
[0133] The results showed that subcutaneous injection of dexamethasone reduced feed intake and daily weight gain, and increased feed conversion ratio in animals; to some extent, Lactobacillus johnsonii B2-3 could alleviate the effects of oxidative stress on the production performance of rabbits.
[0134] Table 4. Effects of Lactobacillus johnsonii B2-3 on the production performance of rabbits under oxidative stress.
[0135]
[0136] Different lowercase letters in the superscript of numerical values indicate significant differences (p<0.05), while different uppercase letters indicate highly significant differences (p<0.01).
[0137] 10.4.2 Slaughter Performance
[0138] Table 5 shows that compared with group C, group B had significantly higher live weight, eviscerated weight, and semi-eviscerated weight (p<0.05), while there were no differences in organs and organ indices between the two groups (p>0.05). Compared with group C, subcutaneous injection of dexamethasone significantly reduced the eviscerated weight, eviscerated percentage, live weight, spleen weight, thymus weight, spleen index, and thymus index in rabbits (p<0.05 or p<0.01), while significantly increasing liver weight, liver index, and kidney index (p<0.01). Compared with group D, supplementation with Lactobacillus johnsonii B2-3 in dexamethasone-injected rabbits significantly increased live weight, semi-eviscerated weight, eviscerated weight, thymus, and thymus index (p<0.05 or p<0.01), while significantly decreasing liver weight and liver index (p<0.05 or p<0.01).
[0139] Table 5. Effects of Lactobacillus johnsonii B2-3 on slaughter performance of rabbits under oxidative stress.
[0140]
[0141] Different lowercase letters in the superscript of numerical values indicate significant differences (p<0.05), while different uppercase letters indicate highly significant differences (p<0.01).
[0142] The results showed that subcutaneous injection of DEX significantly increased liver weight, liver index, and kidney index, significantly decreased eviscerated portion, spleen and its organ index, and significantly decreased spleen index. The addition of Lactobacillus johnsonii B2-3 improved slaughter performance and provided some protection against the effects of dexamethasone.
[0143] 10.4.3 Blood Biochemical Indicators
[0144] As shown in Table 6, compared with group C, supplementation with Lactobacillus johnsonii B2-3 alone had no significant effect on ALP, AST, ALT, TBA, ALB, GLU, TG, TC, and COR (p>0.05); compared with group C, group D had significantly increased serum ALP, TP, ALB, TG, COR, AST, and TBA (p<0.05 or p<0.01); compared with group D, group BD had significantly decreased serum TP, ALB, ALP, TBA, TG, UA, and COR (p<0.05 or p<0.01).
[0145] Table 6. Effects of Lactobacillus johnsonii B2-3 on serum biochemistry in rabbits under oxidative stress.
[0146]
[0147] Different lowercase letters in the superscript of numerical values indicate significant differences (p<0.05), while different uppercase letters indicate highly significant differences (p<0.01).
[0148] The results showed that subcutaneous injection of dexamethasone increased the levels of serum ALP, ALT, AST, TBA, TP, ALB, TG, UA, and COR. Lactobacillus johnsonii B2-3 alleviated the changes in serum biochemical indicators in rabbits induced by Dex to some extent.
[0149] 10.4.4 Serum antioxidant indicators
[0150] like Figure 5 As shown, compared with group C, group D had significantly higher MDA levels (p<0.05), while T-AOC, SOD, and GSH-Px levels were significantly lower, indicating that subcutaneous injection of Dex significantly reduced the antioxidant capacity of rabbits (p<0.05, p<0.01, or p<0.001). In contrast, the activities of T-AOC and GSH-Px in group BD were significantly higher than those in group D (p<0.05 or p<0.01), suggesting that *Lactobacillus johnsonii* can alleviate oxidative stress by increasing antioxidant enzyme levels. 10.4.5 Liver Histopathological Results
[0151] like Figure 6 As shown, compared with group C, the liver morphology of rabbits in group D was abnormal, with a large number of red blood cells accumulating in the interlobular veins, moderate to severe destruction of the hepatic cord structure, deep staining, disappearance or shrunken nuclei, severe edema of hepatocytes, vacuolar degeneration, and severe liver tissue damage. Groups BD and D showed similar pathological changes to group D, with swollen and deformed hepatocytes, but the cytoplasm of hepatocytes was looser and less stained, the hepatic cords were more neatly arranged, the degree of congestion in the central vein and interlobular veins was reduced, and the focal lymphatic infiltration was improved.
[0152] 10.4.5 Determination of intestinal morphology and structure
[0153] As shown in Table 7, the jejunal villus height in group B was slightly higher than that in group C, but the difference between the two groups was not significant (p>0.05); compared with group C, the jejunal villus height in group D was significantly lower (p<0.01); compared with group D, the jejunal villus height in group BD was significantly higher (p<0.01); the jejunal crypt depth in group C was higher than that in groups B and D, but the difference was not significant (p>0.05); compared with group D, the ileal villus height in groups C and BD was significantly higher (p<0.01); the ileocrypt-to-vaginal ratio in groups C and BD was significantly higher than that in group D (p<0.05). The results indicate that adding Lactobacillus johnsonii B2-3 can increase villus height and improve intestinal health.
[0154] Table 7. Effects of Lactobacillus johnsonii B2-3 on intestinal morphology and structure in rabbits under oxidative stress.
[0155]
Claims
1. Lactobacillus johnsonii of rabbit origin (Lj-2) Lactobacillus johnsonii ) B2-3, characterized in that, The accession number is CCTCCNO: M 2023606.
2. The use of the rabbit-derived Lactobacillus johnsonii B2-3 as described in claim 1 in the preparation of products for preventing and treating animal infections with Escherichia coli, Salmonella enteritidis, Listeria monocytogenes, or Clostridium perfringens.
3. The application of the rabbit-derived Lactobacillus johnsonii B2-3 as described in claim 1 in the preparation of feed to alleviate oxidative stress in rabbits.
4. An animal microbial preparation, characterized in that, Contains the rabbit-derived Lactobacillus johnsonii as described in claim 1 ( Lactobacillus johnsonii )B2-3.
Citation Information
Patent Citations
Lactobacillus johnsonii (Ljohn-1) and applications thereof
CN110777087A
Lactobacillus johnsonii and application thereof
CN110878266A
Lactobacillus johnsonii and application thereof
CN111534447A
Lactobacillus johnsonii capable of relieving diarrhea caused by ETEC and application of lactobacillus johnsonii
CN113234643A
Lactobacillus johnsonii IDCC9203 having effect of preventing and treating inflammation, and uses thereof
KR1020190048732A
